Company intelligence / Profile preview

Isaac Melamed

Aurora, Colorado, United Statesveroshealth.com ↗

Ownership: Private
Development stage: Other

Overview

Dr. Isaac Melamed’s clinics are recognized for leadership in immunology and immune-related disease management. The group conducts early diagnosis and intervention for optimal patient health outcomes. They serve as clinical trial sites for investigational therapies in immunology, including late-stage studies such as hereditary angioedema treatments.

No proprietary drugs or technologies are developed by the company itself.

Therapeutic areas: ImmunologyNeurology
Industry: Non-Academic Healthcare

Partnerships

Soleo Health (joint venture partner in Veros Biologics/Veros Health)

Beyond the preview

Go deeper on Isaac Melamed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isaac Melamed.

Explore the full profile